Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

CONCLUSION: The efficacy of capecitabine was found lower compared to previous studies. Selected patients may have further benefit from addition of capecitabine. The toxicity associated with capecitabine was found lower than anticipated.PMID:38568074 | DOI:10.1080/14656566.2024.2337261

Source: Expert Opinion on Pharmacotherapy - April 3, 2024 Category: Drugs & Pharmacology Authors: Elif Şenocak Taşçı Yasin Kutlu Ömer Fatih Ölmez Arda Ula ş Mutlu Yasemin G ündoğdu Mustafa Seyyar Elif Şahin Devrim Çabuk Nargiz Majidova İrem Uğurlu Ay şe Demirci Din çer Aydın Ey üp Çavdar Selami Bayram Nilg ün Yıldırım Fatih Karat Source Type: research